Podcast, News & Publications

Peace in strength. Like the mighty oak that has survived some 600 years in what is now my back yard, we engage with experience and resilience. Whether the winds blow hard or the sun shines bright, we go on, deeply rooted and stretching for the heavens.

Strength in peace. Many challenges of the world, and Pharmaceutical R&D, grow out of mere misunderstandings. We seek to enhance mutual understanding and peaceful cooperation toward shared objectives.

“For me it was a question of dying and going to heaven for 32 years.” Dr. Kieran Geoghegan was inspired by the scientific and technological breakthroughs of the NASA programs in the 1960’s. This became a lifelong quest to get to the bottom of things and resulted in a wonderful career…

Rob Weker’s story is remarkable for many reasons. First and foremost, he has beaten cancer. Not once. Not twice. But three times. Getting the third diagnosis, this time it was pancreatic cancer, really got his attention. Only 7% of pancreatic patients live beyond 5-years. I met Rob at last year’s Patients…

This month listen to Dr. Carol Marzetta talk about how the urge to help other people has shaped her career and her life. From her earliest days as a Discovery Biologist, she has found her passion in work that tries to help people in need. She shares with us some stories about…

We’ve all been there. You are at a party and someone asks, “So, what do you do?” Dr. Kirsch always found it hard to explain his career as a discovery scientist. He decided to write a book about it. The Drug Hunters: An Improbable Quest to Discover New Medicines is a colorful, fact-filled narrative history of…

David Pearce Ph.D., Sanford Research Leader Today we hear from David Pearce, PhD, President of Innovation and Research, Sanford Health and Vice Chair, Consortium Assembly, International Rare Disease Research Consortium (IRDiRC) Dr. Pearce’s rare disease background emanates from publishing over 100 research papers on Batten Disease. David talks to us about…

We welcome Kyle Bryant of the Friedreich’s Ataxia Research Alliance (FARA) to discuss his journey as a patient with Friedreich’s Ataxia (FA), as an active patient leader, and in his job as a liaison between the FA community and researchers. After being diagnosed with FA when only 17 years old,…

Chasing My Cure: A Doctor’s Race to Turn Hope Into Action We are honored to have Dr. David Fajgenbaum as our first guest on Improbable Developments. His story is intense. Before he even earned is medical degree, he was faced by a rare life-threatening illness for which there was no…

News & Publications

In a recent article in the WSJ, Dr. Scott Gottlieb, former head of FDA, described the landscape of potential treatments and preventative measures currently under development. The subtitle of the article was “Antivirals and antibody therapies are showing promise. The FDA needs to pick up its pace.” The article was…

2020 is off to QUITE a start. If someone had said that 2020 would start off this way, I wouldn’t even begin to believe what they were telling me. It would be almost laughable. Yet, this is reality. Our day-to-day lives have drastically changed, worldwide. We are coming together at…

Salem Oaks is an education company, so you may ask why we’re now producing two different podcasts. We believe that an important part of achieving our vision, of a world in which people are equipped to collaborate to successfully shape the health ecosystem of the future, is showing all stakeholders that everyone in medicine is a person…

This is a story you want to follow Imagine the excitement of becoming a new parent and then within hours finding out your child has a serious developmental disorder. What would your reaction be? Where would you go for help? Who would you call? There are no instructions for a…

But Why? When Kevin Freiert started Salem Oaks in the early days of his retirement, he could have focused on any number of topics that he became an expert in during his 30 years at Pfizer. But instead his interest was drawn to a topic that was just starting to…

At Salem Oaks, we believe that people learn better by doing than by being fed information. Think about it. How many lectures from school do you remember? I mean really remember. Now, can you think of an experience you had that taught you something important, that you still remember even…

If you’ve read our previous two articles you know why Salem Oaks focuses on patient education, you know a bit about what problem based learning is and why it’s our preferred method, but can you see how you or your organization can use what we offer? The Friedreich’s Ataxia Research Alliance (FARA) is “dedicated to…

FOR IMMEDIATE RELEASE Contact: Heather McCullen, Salem Oaks LLC Phone: 518.791.8812 Email: heathermccullen@salemoaks.com Salem Oaks and The Friedreich’s Ataxia Research Alliance Are Partnering on Course on Clinical Trial Protocols January 3, 2020—Salem Oaks, LLC and The Friedreich’s Ataxia Research Alliance (FARA) are excited to announce a partnership to offer a new learning opportunity…